Purchase Order 36C25026P0572
- Not listed
- Cardinal Health, Inc. was awarded a $285,000 purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to deliver YESCARTA (axicabtagene ciloleucel) injections for cancer treatment. As the prime contractor, Cardinal Health will provide the chimeric antigen receptor T-cell immunotherapy drug manufactured by Kite Pharma, Inc. from its manufacturing facility in Dublin, Ohio for administration to veterans through VA medical centers...
- This is a federal contract award from the Defense agency Medical Supply Chain to Cardinal Health, Inc., a global healthcare services and products company, for pharmaceutical and medical supplies. The contract has a ceiling value of $1,125.40 and is a delivery order contract with a firm fixed price pricing type. The award is not set aside for any specific business type, indicating Cardinal Health's ability to compete on an unrestricted basis. The contract has an ultimate completion date of...
- This is a firm fixed-price delivery order contract awarded by the Defense Department's Medical Supply Chain agency to Cardinal Health, Inc., a global healthcare services and products company. The contract has a ceiling value of $2,278.55 and an ultimate completion date of January 8, 2025. It is not set aside for any specific business type. The contract provides pharmaceutical and medical supplies to the Department of Veterans Affairs (VA) and other federal healthcare agencies. Cardinal Health...
- This is a federal contract award from the Defense agency, specifically the Medical Supply Chain, to Cardinal Health, Inc. for the provision of pharmaceutical and medical supplies. The contract has a ceiling value of $1,003.18 and is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business type. Cardinal Health, Inc., a global healthcare services and products company, is the prime contractor. The contract is associated with a larger...
- <p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA) awarded a $307,114.91 purchase order to Cardinal Health, Inc., doing business as Cardinal Health, for emergency TECARTUS infusion services. Cardinal Health, Inc. will provide these services as the prime contractor from April 25, 2023 through May 3, 2023 in Dublin, Ohio under a firm fixed price contract structure. No subcontractors were identified.</p>
- This is a federal contract award from the Defense agency with the Medical Supply Chain, with a contract value of $2,417.47. The contract was awarded to Cardinal Health, Inc., a global healthcare services and products company, for the provision of pharmaceutical and medical supplies to the agency. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $6,950,000.00 with the Veterans Integrated Service Network 21, focused on supplying radiopharmaceutical...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded a $153,947.27 firm fixed price delivery order to Cardinal Health 414, LLC for radiopharmaceutical products and services. As the prime contractor, Cardinal Health 414 is a division of Cardinal Health, Inc., a major medical products and services provider. This order was awarded on December 1, 2020 with a completion date of November 30, 2021 to support the VA's healthcare programs in...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed-price delivery order contract to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract, valued at $107,439.95, is for the provision of pharmaceutical products and related services, including radiopharmaceuticals, to support nuclear medicine, oncology, and other patient care programs at VA hospitals and clinics. The contract runs for one year from June 15, 2020, to June 14,...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA) awarded a $287,923.29 purchase order to Cardinal Health, Inc., doing business as Cardinal Health, for EMERGENCY-YESCARTA. The prime contractor, Cardinal Health, Inc., a subsidiary of Cardinal Health, will provide the products or services defined in the EMERGENCY-YESCARTA solicitation from their place of performance in Dublin, Ohio, between November 30, 2022 and December 2, 2022. The...
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 5 (VISN 5), a division of the Department of Veterans Affairs (VA), to Cardinal Health, Inc. The $362,744.04 contract is for the delivery of various pharmaceutical and medical products, including prescription medications, over-the-counter drugs, vaccines, radiopharmaceuticals, and other medical consumables, to support the VA's healthcare operations. The contract has a base period of performance...
The Department of Veterans Affairs, Veterans Integrated Service Network 10, awarded a firm fixed-price purchase order to Cardinal Health, Inc. for the supply of Carvykti medication. The contract, issued on February 6, 2026, carries a ceiling value of $384,718.69 with an ultimate completion date of February 28, 2026. The award was made on an unrestricted, full and open competition basis with no set-aside designation. Cardinal Health will perform the work from its Dublin, Ohio location, where the company maintains its global headquarters and serves as a critical supplier of specialized medical products and pharmaceuticals to federal agencies. Cardinal Health, a registered federal contractor since 2001, brings substantial experience supplying time-sensitive medical products to the Department of Veterans Affairs and other federal healthcare agencies. The company operates through multiple specialized subsidiaries including Cardinal Health 414, LLC, which focuses on radiopharmaceuticals and nuclear medicine products, and Cardinal Health 108, LLC, which supplies specialized pharmaceuticals. Carvykti, a chimeric antigen receptor T-cell (CAR-T) immunotherapy treatment, aligns with Cardinal Health's established role in delivering advanced oncology and specialized therapeutic products to VA medical centers nationwide to support comprehensive healthcare delivery across the Veterans Health Administration system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $384.7k | 2/5/26 |